FTN: SC ruling on Novartis: Should cancer drugs be cheaply available?

Sagarika Ghose, CNN-IBN | Apr 02, 2013 at 11:31pm


In a landmark verdict, the Supreme Court of India dismissed a plea by the Swiss pharmaceutical giant Novartis on Monday for a patent on its cancer drug Glivec, paving way for more affordable life saving drug.